MCRI Radio Show: Let's CURE myeloma! CAR T cells may just be the way to do it. Tune in Weds, May 27 11A CST

Tune in to Wednesday's Myeloma Crowd Research Initiative's show! This project could be a CURE for multiple myeloma! Let's WIN this battle. I think we are SO close. From www.myelomacrowd.org.
   

Our Next Show: The power of CAR T cells in Multiple Myeloma with Dr. Einsele and Hudecek, University of Würzburg, Wednesday, May 27 @ 11 CST

Call In by Phone to Listen Live: (347) 637-2631 or Listen Live Via Computer

CAR T cells are a hot topic in multiple myeloma as an extremely powerful and potentially curative therapy. It is a highly personalized treatment because the patient’s own T-cells are redirected to eliminate cancerous cells using a targeted protein found on the myeloma cells. Learn what Dr. Hermann Einsele, MD and Dr. Michael Hudecek, MD are doing with CAR T cells to target the CS1 protein, commonly found on myeloma cells. 

Hermann Einsele, MD, is Professor of Internal Medicine and Director of the Department of Internal Medicine at the University of  Würzburg in Germany. Following his medical training at the Universities of Tubingen, Manchester, London and Seattle, he became a research fellow in the Department of Hematology/Oncology/Rheumatology/Immunology at the University of Tubingen, Germany. He was board certified in internal medicine in 1991 and became Assistant Professor in 1992. In 1996, he was board certified in hematology/oncology. He is a Visiting Professor at the Fred-Hutchinson-Cancer-Research-Center in Seattle, USA and the City of Hope Hospital, Duarte, USA.

Professor Einsele is a member of the American Society of Hematology, the European Group for Blood and Marrow Transplantation (EBMT), and the EBMT working parties for Infectious Disease and Immunobiology. He is currently a member of the board of the German Society of Blood and Marrow Stem Cell Transplantation. In 1999, he became Chairman of the German Study Group Multiple Myeloma. In 2003, he received the van Bekkum-Award of the European Society of Blood and Marrow Transplantation. He has published > 350 articles in peer-reviewed journals. His research interests include multiple myeloma, stem cell transplantation and adoptive immunotherapy. He is a member of the board of the German Lymphoma Group. In April 2011 he was elected Honorary Fellowship of the Royal College of Pathologists (London).

Dr. Michael Hudecek, MD,  leads the CAR T cell lab work at the University ofWürzburg. Dr. Hudecek obtained his MD with summa cum laude from the University of Leipzig, Germany, and performed his post-doctoral research fellowship at the Fred Hutchinson Cancer Research Center in Seattle, WA, USA. Dr. Hudecek joined the University of Würzburg in 2012 as a clinical fellow and research group leader.

MCRI Radio Show - The next in our series. Let's find that cure for myeloma!

This past week, I met a woman on Twitter who lives in Salt Lake City and is heading into her first stem cell transplant. Another myeloma warrior in my neighborhood. I'm going to visit her on Sunday. I also found another woman on Facebook who is in Salt Lake City living with multiple myeloma. I just picked up Tom Brokaw's book where he talks about his multiple myeloma diagnosis and fight to get well. Is it me or does it seem like way too many people (growing numbers) are affected by multiple myeloma? So my response? Let's find that cure-- especially for high risk disease. And regardless of how aggressive myeloma starts out as, as time progresses, it will eventually become high risk if it isn't already. Because those pesky myeloma cells are wily and smart. But we can be smarter and stomp it out.

Here's the latest upcoming radio show in which my fellow myeloma warrior, Jenny Ahlstrom, is interviewing doctors who are on a quest to either cure myeloma or take one huge step forward in making it a permanently manageable disease. Join me in tuning in. And learn more by visiting www.myelomacrowd.org/mcri or www.myelomacrowd.org.

Myeloma Crowd's MCRI Radio Show - Which multiple myeloma cells are evading treatment? Learn more from Dr. Gareth Morgan, Dr. Niels Weinhold and Dr. Christoph Heuck from UAMS this Monday @ 11 am CST

Monday, May 18,  9 am PST, 10 am MST, 11 am CST, Noon EST
Call In by Phone to Listen Live: (347) 637-2631 or Listen Live Via Computer

Which myeloma cells are the most aggressive and resistant to treatment? Drs. Morgan, Weinhold and Heuck seek to understand where the most aggressive clones are coming from. Is it from clones that adapt the best to the bone marrow environment? Research is showing that patients with several different types of myeloma cells at diagnosis seem to have early relapse and shorter survival while patients with one dominant type of myeloma cell tend to do better.  Learn what the team is doing to find out which clones are the most aggressive and which therapies could actually induce stress and increase the mutation rate, leading to a more resistant myeloma clone.

Gareth Morgan, M.D. FRCP, FRCPath, Ph.D, Professor of Medicine, is the Director of the Myeloma Institute at UAMS.  He is also the deputy director of the Winthrop P. Rockefeller Cancer Institute at UAMS.  Dr. Morgan came to UAMS from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London where he was a Professor of Haematology and Director of the Centre for Myeloma Research.

Dr. Morgan is an internationally recognized clinician scientist who works in the field of molecular genetics of blood cell cancers, in particular, multiple myeloma.  He is specifically interested in how this knowledge can improve the treatment of cancer.

Before coming to the Myeloma Institute, Dr. Morgan served as a professor of Hematology and director of the Centre for Myeloma Research at the Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London, Europe’s largest comprehensive cancer institute. He is also a founding director of the European Myeloma Network and has authored more than 450 peer-reviewed journals.

Dr. Niels Weinhold, PhD is Research Assistant Professor at UAMS. His field of study includes the genetics of multiple myeloma, minimal residual disease, and diagnostics in multiple myeloma. Prior to his coming to UAMS he was a Postdoctoral Fellow in the Department of Internal Medicine at the University of Heidelberg, in Germany.

Dr. Christoph Heuck, MD, is Assistant Professor of Medicine at the Myeloma Institute for Research & Therapy.  He completed a hematology/oncology fellowship at Montefiore Medical Center and an Internal Medicine residency at Jacobi Medical Center, both in New York. Dr. Heuck is board certified by the American Board of Internal Medicine. He received his medical degree in 2003 from Humboldt University in Berlin, graduating magna cum laude.

Dr. Heuck has conducted research related to molecular genetics of multiple myeloma and other cancers.  He is board certified in Internal Medicine and board eligible in Hematology and Oncology.  Dr. Heuck is a member of the American College of Physicians, American Medical Association, American Society of Clinical Oncologists and American Society of Hematology.

Cure Panel Talk Radio Recap: A Chat with MMRF

It's been awhile since I've written about Myeloma. Instead, I've been talking more to the divorced community. Sometimes, I get so tired of talking about Myeloma that I just need a break. It's always heavily on my mind, though. How can it not be? Everything I do, say, eat and breathe has something to do with Myeloma.

So I'll start writing about Myeloma more in the near future. After all, next week, I'll have a very exciting announcement. I've been working extensively with my friend Jenny, fellow Myeloma warrior and a champion of Myeloma causes. She is my inspiration. Anyway, I'll fill you in on the details in a few days but I can hardly wait.

That said, the latest Cure Panel Talk Show is ready for your listening On the show, the Cure Panel talked to the Anne Quinn Young of the MMRF, which has some interesting and exciting news to share about the latest in MMRF initiatives, Community Gateway, big data and more. To listen in, click here:

Cure Panel Talk Radio Show - Thurs, 12/16: Total Therapy for Myeloma

Well this is one Cure Panel that I won't miss! Are we close to curing myeloma, not just treating it? I think so! Tune in for details. I definitely will!

Thurs, Dec 16 at 6PM ET, featuring Dr.van Rhee of UAMS/Little Rock to discuss Total Therapy for Myeloma. Total Therapy treatment option for myeloma indicates towards a cure for the condition.

 

To RSVP, click here:http://curepanel.carefeed.net/event/rsvp/12/